Literature DB >> 2409146

Mast cell heterogeneity: effects of neuroenteric peptides on histamine release.

F Shanahan, J A Denburg, J Fox, J Bienenstock, D Befus.   

Abstract

Recent reports suggesting that the actions of certain neuroenteric peptides may be mediated in part by the secretion of histamine and other mast cell contents could have important implications for gastrointestinal motility and secretion. However, evidence for a mast cell-hormonal interaction is based on studies using peritoneal or cutaneous mast cells. Because intestinal mucosal mast cells (MMC) differ functionally from peritoneal mast cells (PMC), we compared the effects of several neurotransmitters and intestinal hormones on histamine secretion from two mast cell types in the rat. MMC hyperplasia was induced in rats by infection with the nematode Nippostrongylus brasiliensis, and MMC were isolated from the small intestine by collagenase digestion. Substance P, somatostatin, vasoactive intestinal polypeptide (VIP), neurotensin, and bradykinin had a potent secretagogue effect on (10(-7) to 10(-4)M) PMC which was temperature-, energy-, and calcium-dependent. In contrast to PMC, MMC released significant amounts of histamine only when challenged with substance P. Acetylcholine, bombesin, motilin, and pentagastrin had no secretory effect on either PMC or MMC. The differences between PMC and MMC in responsiveness to peptides could not be attributed to the MMC isolation procedure because PMC treated similarly or mixed with MMC suspensions retained their responsiveness to these stimuli. Our results extend the concept of neurocrine control of mast cell function, but indicate that mast cells from different sites have distinct profiles of responsiveness to regulatory peptides.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409146

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

1.  Optimization of an Acridine Orange-bisbenzimide procedure for the detection of apoptosis-associated fluorescence colour changes in etoposide-treated cell cultures.

Authors:  Nadia L Landex; Lars Kayser
Journal:  J Mol Histol       Date:  2004-02       Impact factor: 2.611

Review 2.  Mast cells.

Authors:  J S Marshall; J Bienenstock
Journal:  Springer Semin Immunopathol       Date:  1990

Review 3.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

Authors:  Scott P Levick; Giselle C Meléndez; Eric Plante; Jennifer L McLarty; Gregory L Brower; Joseph S Janicki
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

4.  Seasonal increase of spontaneous histamine release in washed leucocytes from rhinitis patients sensitive to grass pollen.

Authors:  A Weyer; M T Guinnepain; J P Sutra; A Borgnon; N Herpin-Richard; M R Ickovic; J Meaume; M Raffard; F Tekaia
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

5.  Formation of contacts between mast cells and sympathetic neurons in vitro.

Authors:  M G Blennerhassett; M Tomioka; J Bienenstock
Journal:  Cell Tissue Res       Date:  1991-07       Impact factor: 5.249

6.  Functional characterization of mast cells generated in vitro from the mesenteric lymph node of rats infected with Nippostrongylus brasiliensis.

Authors:  F Shanahan; T D Lee; J A Denburg; J Bienenstock; A D Befus
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

7.  Real-time reverse transcription-PCR quantitation of substance P receptor (NK-1R) mRNA.

Authors:  Jian-Ping Lai; Steven D Douglas; Yan-Jian Wang; Wen-Zhe Ho
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

8.  Activation of human neutrophils by tachykinins: effect on formyl-methionyl-leucyl-phenylalanine- and platelet-activating factor-stimulated superoxide anion production and antibody-dependent cell-mediated cytotoxicity.

Authors:  A Wozniak; W H Betts; G McLennan; R Scicchitano
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor.

Authors:  L A Miller; D E Cochrane; R E Carraway; R S Feldberg
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Role of vasoactive intestinal peptide (VIP) in pathogenesis of ethanol-induced gastric mucosal damage in rats.

Authors:  F Karmeli; R Eliakim; E Okon; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.